Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 78.70
Bid: 77.60
Ask: 81.00
Change: -1.90 (-2.36%)
Spread: 3.40 (4.381%)
Open: 78.80
High: 78.90
Low: 78.60
Prev. Close: 80.60
KYGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kerry Launches EUR300m Share Buyback Programme

1 Nov 2023 07:00

RNS Number : 9251R
Kerry Group PLC
01 November 2023
 
 

1 November 2023

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP PLC

Regulatory Announcement

KERRY GROUP PLC LAUNCHES ?300m SHARE BUYBACK PROGRAMME

On 26 October 2023, Kerry Group plc ("Kerry" or the "Company") announced its intention to launch a share buyback programme of up to ?300 million (the "Buyback Programme"). The Buyback Programme is underpinned by the Group's strong balance sheet and cash flow and is aligned to Kerry's Capital Allocation Framework.

Kerry announces that, pursuant to the Buyback Programme, it has entered into non-discretionary arrangements with J&E Davy and Goldman Sachs International (the "Banks") to purchase up to ?300 million of Kerry's A Ordinary Shares of ?0.125 each (the "Shares") on its behalf, and to make trading decisions under the Buyback Programme independently of Kerry in accordance with certain pre-set parameters.

The Buyback Programme will commence today, 1 November 2023 and will end no later than 30 April 2024. All Shares will be purchased by the Banks on the Company's behalf (on a riskless principal basis) on Euronext Dublin for subsequent repurchase by the Company on Euronext Dublin or the London Stock Exchange.

The purpose of the Buyback Programme is to reduce the share capital of the Company and as such, the Company will cancel any Shares repurchased.

The Buyback Programme will be carried out within certain pre-set parameters and within the limitations of the share buyback authority granted at Kerry's Annual General Meeting on 27 April 2023 and any renewal of that authority. The maximum number of Shares that may be purchased under the Buyback Programme is 17,707,452 Shares.

The Buyback Programme will be conducted in accordance with the relevant provisions of the Market Abuse Regulation 596/2014/EU ("MAR" and including MAR as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and the Commission Delegated Regulation (EU) 2016/1052 (including as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) as well as the rules of the Central Bank of Ireland.

Any repurchase of Shares will be announced no later than 7:30am on the business day following the calendar day on which the repurchase occurred.

 

CONTACT INFORMATION

 

Group Secretary

 

Ronan Deasy

 

+353 66 7182000 | TraleeCoSec@kerry.ie

Website

 

www.kerry.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUARBROKUROAA
Date   Source Headline
2nd Aug 20229:00 amRNSTotal Voting Rights
29th Jul 20227:00 amRNSKerry Group Interim Management Report 2022
1st Jul 20228:54 amRNSBlock listing Interim Review
1st Jul 20228:40 amRNSTotal Voting Rights
20th Jun 202210:23 amRNSHolding(s) in Company
1st Jun 202210:03 amRNSTotal Voting Rights
3rd May 202212:57 pmRNSTotal Voting Rights
28th Apr 20224:32 pmRNSDirectorate Change
28th Apr 20224:29 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 Interim Management Statement 2022
4th Apr 20221:42 pmRNSStatement re Russian and Belarus Operations
1st Apr 202211:22 amRNSTotal Voting Rights
25th Mar 202212:55 pmRNSNotice of AGM
16th Mar 20221:50 pmRNSHolding(s) in Company
16th Mar 20221:39 pmRNSDirector/PDMR Shareholding
15th Mar 20224:45 pmRNSDirector/PDMR Shareholding
11th Mar 20224:03 pmRNSDirector/PDMR Shareholding
11th Mar 20223:59 pmRNSDirector/PDMR Shareholding
11th Mar 20223:55 pmRNSDirector/PDMR Shareholding
11th Mar 202212:13 pmRNSAnnual Financial Report
1st Mar 20229:50 amRNSTotal Voting Rights
25th Feb 20223:14 pmRNSDirector/PDMR Shareholding
16th Feb 20227:00 amRNSPreliminary Statement of Results 31 December 2021
15th Feb 202211:29 amRNSNotice of Results and AGM
15th Feb 20227:00 amRNSKerry – strategic biotechnology acquisitions
1st Feb 20222:21 pmRNSTotal Voting Rights
4th Jan 20223:00 pmRNSBlock listing Interim Review
4th Jan 202212:00 pmRNSTotal Voting Rights
13th Dec 202110:31 amRNSDirectorate Change
9th Dec 202112:17 pmRNSDirector/PDMR Shareholding
1st Dec 202112:26 pmRNSTotal Voting Rights
29th Nov 20211:28 pmRNSDirector/PDMR Shareholding
24th Nov 20215:41 pmRNSKerry - EUR750m Sustainability-Linked Notes
1st Nov 202111:20 amRNSTotal Voting Rights
27th Oct 20217:00 amRNSQ3 Interim Management Statement 2021
13th Oct 20217:00 amRNSKerry Strategic Update – Capital Markets Day
1st Oct 20219:20 amRNSTotal Voting Rights
27th Sep 20217:00 amRNSKerry Completes Sale of Meats & Meals Business
14th Sep 20217:00 amRNSKerry completes acquisition of Niacet
2nd Sep 202111:54 amRNSHolding(s) in Company
1st Sep 202111:22 amRNSHolding(s) in Company
1st Sep 202111:02 amRNSTotal Voting Rights
18th Aug 20214:11 pmRNSDirector/PDMR Shareholding
6th Aug 20214:20 pmRNSHolding(s) in Company
3rd Aug 202111:17 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSKerry Group Interim Management Report 2021
8th Jul 20217:00 amRNSResult of public tender offer for Biosearch Life
1st Jul 202112:22 pmRNSBlock listing Interim Review
1st Jul 202110:00 amRNSTotal Voting Rights
28th Jun 20215:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.